NRXBF READ THE FULL NRXBF RESEARCH REPORT NurExone (OTC:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting ...

Study uncovers new insights into pain pathways associated with temporomandibular joint (TMJ) disorders. Using an innovative in vivo imaging tool to capture functional activity in mouse models of TMJ ...

Current treatments often fall short, prompting researchers to explore the intricate nerve and vessel network surrounding TMJ ... from both TMJ pain and hypersensitivity in the trigeminal ganglion ...

Fast track was first introduced by FDA to expedite development and review of drugs to treat serious conditions lacking any FDA-approved drug,” commented Gary S. Jacob, Ph.D., Chief Executive Officer ...

But in GBS, the immune system starts to destroy the myelin sheath that surrounds the axons of many nerve cells, and sometimes, the axons themselves. When this occurs, the nerves can’t send signals ...

Poor retinal health in midlife is associated with increased risk for Alzheimer’s disease and related dementias later on, ...

The most common cause of ulnar tunnel syndrome is a ganglion cyst. That’s a noncancerous growth filled with fluid that develops on your wrist and can press on your ulnar nerve. But you can ...

A carpal boss is often mistakenly misdiagnosed as a ganglion cyst because of the similarity in appearance and location. Unlike a ganglion cyst, a carpal boss is not movable under the skin. Bone spurs ...

An abnormal form of the tau protein found to accumulate in the brains of Alzheimer's disease patients also accumulates in the eyes of patients with the condition, according to new findings from Cedars ...

Ulnar nerve entrapment happens when there’s pressure on the ulnar nerve. The ulnar nerve travels from the shoulder to the pinky finger. It can cause symptoms like muscle weakness and numbness.

The center–surround receptive-field organization in retinal ganglion cells is widely believed to result mainly from lateral inhibition at the first synaptic level (in the outer retina).